|
|
Article: Research and Markets: This Comprehensive Pharmacogenomics for Clinical Use and in Drug Development Report is Now Available.
- Article from:
- Business Wire
- Article date:
- June 3, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/1601ab/pharmacogenomics_f) has announced the addition of the "Pharmacogenomics for Clinical Use and in Drug Development" report to their offering.
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the ...